To Estimate the Potential Effects of Repeat Doses of Darapladib on the Pharmacokinetics (PK) of Rosuvastatin as Well as Evaluating Safety and Tolerability in Healthy Volunteers
This study has been completed.
First Posted: December 17, 2012
Last Update Posted: July 26, 2017
Information provided by (Responsible Party):